South Korean molecular diagnostics (MDx) company Seegene has developed the Novaplex MPXV Assay to detect the monkeypox virus.
The Novaplex MPXV Assay is a real-time polymerase chain reaction (PCR) product that specifically detects the monkeypox virus target gene using the company’s TOCE technology.
Go deeper with GlobalData
Reports
Cytomegalovirus (CMV) Tests Market Size (Value, Volume, ASP) by Seg...
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Find out more
It has been developed using Seegene’s artificial intelligence (AI)-based automated test development system, called Seegene Digitalized Development System (SGDDS), and technologies.
Used as a confirmation test for monkeypox virus infection, the assay provides a convenient workflow with a streamlined automation system.
The test can identify positive monkeypox virus cases within 90 minutes of testing.
According to the World Health Organization (WHO), the monkeypox virus is an evolving health threat, which needs collective attention and coordinated action. The organisation has urged member states to increase surveillance, contact tracing and testing.
GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData Learn more about Strategic Intelligence
Seegene CEO Dr Jong-Yoon Chun said: “The monkeypox virus outbreak shows that endemic viruses can rapidly spread to the rest of the world and it’s a warning that new pandemics can emerge and threaten our lives at any time.
“We will continue our efforts to develop products that can accurately diagnose any virus to help prevent new infectious diseases from taking hold and becoming a pandemic.”
The company stated that it has developed the new Novaplex MPXV Assay to help control the spread of the virus across the world.
It is planning to provide the new assay to countries that have detected the virus.
In April, Seegene received approval from Australia’s Therapeutic Goods Administration (TGA) for its Allplex RV Master Assay, which can identify three Covid-19 genes, as well as Flu A, Flu B and metapneumovirus.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Go deeper with GlobalData
Reports
Cytomegalovirus (CMV) Tests Market Size (Value, Volume, ASP) by Seg...
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Find out more
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Give your business an edge with our leading industry insights.
close close
Sign up to the newsletter: In Brief
Industry * Academia & Education Aerospace, Defense & Security Agriculture Asset Management Automotive Banking & Payments Chemicals Construction Consumer Foodservice Government, trade bodies and NGOs Health & Fitness Hospitals & Healthcare HR, Staffing & Recruitment Insurance Investment Banking Legal Services Management Consulting Marketing & Advertising Media & Publishing Medical Devices Mining Oil & Gas Packaging Pharmaceuticals Power & Utilities Private Equity Real Estate Retail Sport Technology Telecom Transportation & Logistics Travel, Tourism & Hospitality Venture Capital Country * UK USA Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica
GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? 
